Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Friede

Showing results (271-280 of 393) with videos related to

Pageof 40
Sort By:
ESC Heart Failure|November 30, 2020
Reporting and interpretation of subgroup analyses in heart failure randomized controlled trialsMuhammad Shahzeb Khan, Muhammad Arbaz Arshad Khan, Simra Irfan, et al.
Statistical Methods in Medical Research|April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic reviewMaximilian Bardo, Cynthia Huber, Norbert Benda, et al.
Nature Medicine|May 10, 2026
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trialJohann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
JACC. Cardiovascular Imaging|May 5, 2022
RT-CMR Imaging for Noninvasive Characterization of HFpEF: Medium-Term Outcomes of the HFpEF Stress TrialSören J Backhaus, Simon F Rösel, Alexander Schulz, et al.
European Heart Journal|August 26, 2024
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trialStephan von Haehling, Wolfram Doehner, Ruben Evertz, et al.
European Heart Journal. Digital Health|January 30, 2023
Applications of artificial intelligence/machine learning approaches in cardiovascular medicine: a systematic review with recommendationsSarah Friedrich, Stefan Groß, Inke R König, et al.
Age and Ageing|May 24, 2024
Evaluating palliative care case conferences in primary care for patients with advanced non-malignant chronic conditions: a cluster-randomised controlled trial (KOPAL)Tina Mallon, Josefine Schulze, Judith Dams, et al.
Annals of Palliative Medicine|October 23, 2023
Cost-effectiveness of a specialist palliative care nurse-patient consultation followed by an interprofessional case conference for patients with non-oncological palliative care needs: results of the KOPAL trialSophie Gottschalk, Hans-Helmut König, Tina Mallon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2023
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trialUrsula Rauch-Kröhnert, Marianna Puccini, Marius Placzek, et al.
Pharmaceutical Statistics|November 21, 2018
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapiesSteffen Unkel, Marjan Amiri, Norbert Benda, et al.
Pageof 40

Showing results (271-280 of 393) with videos related to

Sort By:
Pageof 40
ESC Heart Failure|November 30, 2020
Reporting and interpretation of subgroup analyses in heart failure randomized controlled trialsMuhammad Shahzeb Khan, Muhammad Arbaz Arshad Khan, Simra Irfan, et al.
Statistical Methods in Medical Research|April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic reviewMaximilian Bardo, Cynthia Huber, Norbert Benda, et al.
Nature Medicine|May 10, 2026
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trialJohann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
JACC. Cardiovascular Imaging|May 5, 2022
RT-CMR Imaging for Noninvasive Characterization of HFpEF: Medium-Term Outcomes of the HFpEF Stress TrialSören J Backhaus, Simon F Rösel, Alexander Schulz, et al.
European Heart Journal|August 26, 2024
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trialStephan von Haehling, Wolfram Doehner, Ruben Evertz, et al.
European Heart Journal. Digital Health|January 30, 2023
Applications of artificial intelligence/machine learning approaches in cardiovascular medicine: a systematic review with recommendationsSarah Friedrich, Stefan Groß, Inke R König, et al.
Age and Ageing|May 24, 2024
Evaluating palliative care case conferences in primary care for patients with advanced non-malignant chronic conditions: a cluster-randomised controlled trial (KOPAL)Tina Mallon, Josefine Schulze, Judith Dams, et al.
Annals of Palliative Medicine|October 23, 2023
Cost-effectiveness of a specialist palliative care nurse-patient consultation followed by an interprofessional case conference for patients with non-oncological palliative care needs: results of the KOPAL trialSophie Gottschalk, Hans-Helmut König, Tina Mallon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2023
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trialUrsula Rauch-Kröhnert, Marianna Puccini, Marius Placzek, et al.
Pharmaceutical Statistics|November 21, 2018
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapiesSteffen Unkel, Marjan Amiri, Norbert Benda, et al.
Pageof 40